Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plasma Solution D and Plasma Solution K are intravenous electrolyte and nutrient replenishment solutions developed and marketed by HK Inno.N (formerly CJ Healthcare). These products are part of the Plasma Solution line of crystalloid infusion fluids, which are designed to maintain or restore fluid and electrolyte balance in patients. Plasma Solution D is an isotonic electrolyte solution supplemented with 5% dextrose (glucose) to provide a source of calories and prevent ketosis, making it suitable for patients requiring both fluid replacement and nutritional support. Plasma Solution K is a related formulation used for electrolyte maintenance. Both solutions are administered via intravenous injection and are approved for use in conditions such as dehydration, electrolyte imbalance, and as a vehicle for the administration of compatible intravenous medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Plasma Solution D + Plasma Solution K.